Although ACE2 has not been reported in ORN, simultaneous damage to sustentacular cells and horizontal basal cells upon infection with SARS-CoV-2 could precede disturbances in olfaction, which have been reported in up to 98% of patients with confirmed COVID-19 [111]. This evidence concerns the gene ACE2 and COVID-19.